冠心宁片联合西药治疗慢性稳定性心绞痛合并抑郁症临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4;R749.4

基金项目:

嘉兴市科技计划项目(2019AD32182)


Clinical Study on Guanxinning Pills Combined with Western Medicine for Chronic Stable Angina Pectoris Complicated with Depression
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察冠心宁片联合西药治疗慢性稳定性心绞痛(SAP) 合并抑郁症的临床疗效。方法:按随机数字表法将80 例慢性SAP 合并抑郁症患者均分为2 组。对照组给予常规西药治疗,观察组在对照组基础上加用冠心宁片治疗,2 组均治疗2 个月。比较2 组临床疗效、不良反应发生率,以及治疗前、治疗1 个月、治疗2 个月中医证候、西雅图心绞痛调查表(SAQ)、抑郁自评量表(SDS)、汉密尔顿抑郁量表-17(HAMD-17)评分。结果:治疗1 个月、2 个月,2 组胸闷胸痛、心悸、气短、精神抑郁、性情急躁评分均较治疗前降低(P<0.05),观察组上述各项中医证候评分均低于同期对照组(P<0.05);2 组躯体活动受限、心绞痛稳定状态、心绞痛发作频率、治疗满意度、疾病认知度评分均较治疗前升高(P<0.05),观察组上述各项SAQ 细则评分均高于同期对照组(P<0.05);2 组SDS、HAMD-17 评分均较治疗前降低(P<0.05),观察组SDS、HAMD-17 评分均低于同期对照组(P<0.05)。观察组总有效率92.50%,高于对照组80.00%(P<0.05)。观察组不良反应发生率7.50%,低于对照组25.00%(P<0.05)。结论:冠心宁片联合西药治疗慢性SAP 合并抑郁症可提高临床疗效,有效缓解临床症状、减轻抑郁程度,且安全性高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Guanxinning Pills combined with western medicine for chronic stable angina pectoris(SAP) complicated with depression. Methods: Eighty cases of chronic SAP patients with depression were average divided into two groups according to the random number table method. The control group was treated with routine western medicine,and the observation group was additionally treated with Guanxinning Pills based on the treatment of the control group. Both groups were treated for two months. Clinical effects and the incidence of adverse reactions were compared between the two groups. Scores of Chinese medicine syndromes, Seattle Angina Questionnaire(SAQ), Self- Rating Depression Scale(SDS), and Hamilton Depression Rating Scale- 17(HAMD- 17) in the two groups before treatment and after one and two months of treatment were compared. Results:After one and two months of treatment,the scores of chest oppression and chest pain,palpitation,shortness of breath,mental depression,and irritability in the two groups were decreased when compared with those before treatment(P<0.05), and the above scores in the observation group were lower than those in the control group during the same period(P<0.05); scores of physical limitations, angina severity, angina frequency, treatment satisfaction and disease awareness in the two groups were increased when compared with those before treatment(P<0.05),and the above five scores in the observation group were higher than those in the control group during the same period(P<0.05);scores of SDS and HAMD- 17 in the two groups were decreased when compared with those before treatment(P<0.05),and the scores of SDS and HAMD- 17 in the observation group were lower than those in the control group during the same period(P<0.05). The total effective rate was 92.50% in the observation group,higher than that of 80.00% in the control group(P<0.05). The incidence of adverse reaction was 7.50% in the observation group,lower than that of 25.00% in the control group(P<0.05). Conclusion: Guanxinning Pills combined with western medicine for chronic SAP complicated with depression can improve clinical effects, effectively relieve clinical symptoms and reduce depression degree with high safety.

    参考文献
    相似文献
    引证文献
引用本文

钱承嗣,孙燕,费玉娥.冠心宁片联合西药治疗慢性稳定性心绞痛合并抑郁症临床研究[J].新中医,2022,54(22):42-46

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-27
  • 出版日期: